Sign in
Wieland-Khanani Port Delivery System
Mark R. Wieland, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
Wet AMD 4 Symposium
Annual Meeting Talks
2020
Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy
Michael W. Stewart, MD
2019
Category: Practice Management